« Back
Home /
Finerenone

Finerenone

Item no.	TMO-T21395-50mg
Manufacturer	TargetMol
CASRN	1050477-31-0
Amount	50 mg
Quantity options	100 mg 10 mg 1 mL 1 mg 200 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Purity	99.65%
Citations	George L Bakris , Rajiv Agarwal ,et al.Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.JAMA. 2015 Sep 1;314(9):884-94.
Smiles	CCOc1ncc(C)c2NC(C)=C([C@@H](c3ccc(cc3OC)C#N)c12)C(N)=O
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	BAY-948862, BAY948862, BAY94-8862, BAY 94-8862, BAY-94-8862, BAY 948862
Shipping condition	Cool pack
Available
Manufacturer - Targets	Glucocorticoid Receptor
Shipping Temperature	cool pack
Storage Conditions	-20°
Molecular Weight	378, 42
Target names or alias	BAY 94-8862 , BAY-94-8862 , BAY948862 , BAY94-8862 , BAY-948862 , BAY 948862
Description	Finerenone (BAY-948862) is a nonsteroidal antagonist of the mineralocorticoid receptor (MR) (IC50=18 nM) with selective and oral activity. Finerenone is used in the treatment of patients with chronic kidney disease with type 2 diabetes.
Pathways	Endocrinology/Hormones

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T21395-50mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Request delivery time